Print PDF

Production Limits for Controlled Substances for 2015 to be Adjusted

Wednesday, July 08, 2015
Sandler, Travis & Rosenberg Trade Report

The Justice Department’s Drug Enforcement Administration is accepting comments through Aug. 7 on its proposal to adjust the 2015 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act. These amounts represent those quantities of the covered substances to be manufactured in the U.S. to provide for the estimated medical, scientific, research and industrial needs of the U.S., lawful export requirements, and the establishment and maintenance of reserve stocks. These quotas do not include imports of controlled substances for industrial processes, and the DEA is not proposing to adjust the 2015 assessment of annual needs for ephedrine, pseudoephedrine and phenylpropanolamine to be manufactured in and imported into the U.S.

To get news like this in your inbox daily, subscribe to the Sandler, Travis & Rosenberg Trade Report.

Customs & International Headlines